A recent study published in the Journal of the American Medical Association (JAMA) about the possible dangers of testosterone replacement therapy is flawed, according to a review by health website Life Extension. The study, titled “Association of Testosterone Therapy with Mortality, Myocardial Infarction, and Stroke in Men with Low Testosterone Therapy” is wrongly discouraging men from properly restoring their testosterone levels.
The methodology of the study had many holes in it, which affects the overall results. For instance, when performing studies on testosterone levels, it is crucial to measure the hormone levels in participants blood frequently. A blood test allows the physicians and researchers conducting the study to make sure subjects are taking their testosterone as directed and that their blood levels are rising as expected. In the research published by JAMA, only 60 percent of participants had their blood assessed regularly, which could lead to false results. On the contrary to what the study proclaims, testosterone therapy, when taken in healthy amounts, boast numerous benefits.
“Over the years, several studies have shown that testosterone replacement therapy to appropriate levels in aging men with low testosterone levels at baseline improve several markers of male vitality, such as bone density, sexual desire, psychological health, and cardiovascular benefit, in contrast to this flawed study,” says Steven V. Joyal, M.D., chief medical officer with Life Extension. “Furthermore, additional data suggests that low testosterone is linked with an increased risk of type 2 diabetes and obesity in aging men.”
If you’re looking to supplement your healthy lifestyle with hormone pellet therapy, contact Longevity Centres of America in Dallas or Denver.